NL-OMON56479尚未招募不适用
The OCEANS II trial: Fluorescence guided surgery with indocyanine green for better visualization of small intestine neuroendocrine tumors: a feasibility study - The OCEANS II trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients with lesions on the 68Ga-DOTATATE-PET-CT scan suspected for a SI-NET;
- •- Patients with biopsy proven SI-NET;
- •- With the primary SI-NET in situ;
- •- >= 18 years old;
- •- Obtained informed consent according to ICH/GCP, and national/local
- •regulations.
排除标准
- •- Patients known with an allergy for iodine, intravenous contrast or shellfish;
- •- Patients with hyperthyroidism;
- •- Patients pregnant or breastfeeding;
- •- Patients with an ASA classification of 4 or higher;
- •- Incapacitated subjects;
- •- Any condition that the investigator, surgeon or anaesthesiologist considers
- •to be potentially jeopardizing the patient*s well-being or the study
- •objectives.
研究者
相似试验
已完成
不适用
The OCEANS trial: fluorescence guided surgery with methylene blue for better visualization of small intestine neuroendocrine tumors: a feasibility study.hormone producing tumorsNeuro-endocrine tumors1002911210017998NL-OMON56617Erasmus MC, Universitair Medisch Centrum Rotterdam17
尚未招募
2 期
The STELLAR trial: Fluorescence-guided surgery in laryngeal- and hypopharyngeal cancer: a feasibility trialcancerNL-OMON54203Erasmus MC, Universitair Medisch Centrum Rotterdam27
招募中
不适用
Efficacy of fluorescence navigation surgery for laparoscopic liver resectioiver tumorsJPRN-UMIN000029864Graduate School of Medicine, Kyoto University Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery and Transplantation20
招募中
4 期
Fluorescence-guided (Minimally Invasive) resections of Colorectal liver metastases - II (MIMIC-II)colorectal liver metastasesmetastases in the liver from primary colon cancer1001981510019818NL-OMON56540eids Universitair Medisch Centrum52
招募中
不适用
Fluorescence guided surgery for intra-operative detection of meningioma using Bevacizumab-IRDye800CWmeningiomaNL-OMON50918niversitair Medisch Centrum Groningen19